Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Verdiva Bio Limited

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaIndustriaSalute

5 comunicati stampa

Guarda tutti i comunicati
30/07/2026
Analisi di mercato
Industria
Scienza
Salute
Fitness
Medicina - Varie
Cardiologia
Biotecnologia
Sanità
Farmaceutica
Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential
Fonte
Verdiva Bio Limited
Emittente
Business Wire
1.00
0
23/07/2026
Mercato del lavoro
Salute
Fitness
Scienza
Farmaceutica
Cardiologia
Biotecnologia
Verdiva Bio Appoints Cardiometabolic Leader Steve Marso as Chief Medical Officer
Fonte
Verdiva Bio Limited
Emittente
Business Wire
1.00
0
05/06/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Fiere
Industria
Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions
Fonte
Verdiva Bio Limited
Emittente
Business Wire
1.00
0
20/06/2025
Verdiva Bio to Present New Data Highlighting Once-Weekly Potential of Its Investigational Oral Obesity Candidates at the ADA 85th Scientific Sessions
Fonte
Verdiva Bio Limited
Emittente
Business Wire
1.00
0
09/01/2025
Industria
Salute
Fitness
Sanità
Medicina - Varie
Farmaceutica
Cardiologia
Biotecnologia
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
Fonte
Verdiva Bio Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0